LEXISCAN(R) (REGADENOSON)
LEXISCAN(R) (REGADENOSON) INJECTION 0.4mg/5mL (0.08 mg/mL) 5mL SYR
Approved
Approval ID
99640071-4db2-9317-e053-2995a90a610d
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 28, 2024
Manufacturers
FDA
HF Acquisition Co LLC, DBA HealthFirst
DUNS: 045657305
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LEXISCAN(R) (REGADENOSON)
PRODUCT DETAILS
NDC Product Code51662-1448
Application NumberNDA022161
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateJanuary 28, 2024
Generic NameLEXISCAN(R) (REGADENOSON)
INGREDIENTS (1)
REGADENOSONActive
Quantity: 0.08 mg in 1 mL
Code: 2XLN4Y044H
Classification: ACTIM